Abstract:Background: Prenatal diagnosis of fetal short long bones (SLBs) was reported to be associated with skeletal dysplasias, chromosomal abnormalities, and genetic syndromes. This study aims to identify the genetic causes for fetal short long bones, and retrospectively evaluate the additional diagnostic yield of exome sequencing (ES) for short long bones following the use of conventional genetic testing. Methods: A cohort of ninety-four fetuses with sonographically identified short long bones was analyzed by trio-exome sequencing between January 2016 and June 2021. Fetuses with abnormal results of karyotype or chromosomal microarray analysis were excluded. Variants were interpreted based on ACMG/AMP guidelines. All diagnostic de novo variants were validated by Sanger sequencing. Results: Of the 94 fetuses, 38 (40.4%) were found to carry causal genetic variants (pathogenic or likely pathogenic) in sixteen genes with 38 variants. Five fetuses (5.3%) had variant(s) of uncertain significance. Thirty-five cases (37.2%) were diagnosed as genetic skeletal dysplasias including 14 different diseases that were classified into 10 groups according to the Nosology and Classification of Genetic Skeletal Disorders. The most common disease in the cohort was achondroplasia (28.9%), followed by osteogenesis imperfecta (18.4%), thanatophoric dysplasia (10.5%), chondrogenesis (7.9%), and 3-M syndrome (5.3%). The diagnostic yield in fetuses with isolated short long bones was lower than the fetuses with non-isolated short long bones, but not reached statistical significance (27.3% vs. 44.4%; p = 0.151). Whereas, the rate in the fetuses with other skeletal abnormalities was significantly higher than those with non-skeletal abnormalities (59.4% vs. 32.5%, p = 0.023), and the diagnostic rate was significantly higher in femur length (FL) below -4SDs group compared with FL 2-4SDs below GA group (72.5% vs. 16.7%; p < 0.001). A long-term follow-up showed that outcomes for fetuses with FL 2-4SDs below GA were significantly better than those with FL below -4SDs. Additionally, fourteen (36.8%) novel short long bones-related variants were identified in the present study. Conclusion: The findings suggest that in fetuses with short long bones routine genetic tests failed to determine the underlying causes, exome sequencing could add clinically relevant information that could assist the clinical management of pregnancies. Novel pathogenic variants identified may broaden the mutation spectrum for the disorders and contributes to clinical consultation and subsequent pregnancy examination.

Application of Targeted Exome Capture in Identifying Fetal Skeletal Malformation Mutations

A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing.

Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China

Whole Exome Sequencing Aids the Diagnosis of Fetal Skeletal Dysplasia

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Non-Invasive Prenatal Diagnosis of Lethal Skeletal Dysplasia by Targeted Capture Sequencing of Maternal Plasma

Study on ultrasound combined with high throughput sequencing in the detection of fetal short limb malformations

Clinical Application of Medical Exome Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies.

Combined Exome Sequencing and Deep Phenotyping in Highly Selected Fetuses with Skeletal Dysplasia During the First and Second Trimesters Improves Diagnostic Yield

Molecular Diagnosis for 55 Fetuses with Skeletal Dysplasias by Whole‐exome Sequencing: A Retrospective Cohort Study

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Exome sequencing in fetuses with short long bones detected by ultrasonography: A retrospective cohort study

Prenatal diagnosis of fetal skeletal anomalies via whole-exome sequencing in a tertiary referral center

Two Novel Mutations of COL1A1 in Fetal Genetic Skeletal Dysplasia of Chinese

Genetics Evaluation of Targeted Exome Sequencing in 223 Chinese Probands with Genetic Skeletal Dysplasias.

Simultaneous CNV-seq and WES: an Effective Strategy for Molecular Diagnosis of Unexplained Fetal Structural Anomalies

Prospective Prenatal Cell-Free DNA Screening for Genetic Conditions of Heterogenous Etiologies

Targeted Next-Generation Sequencing Identifies Novel Compound Heterozygous Mutations of DYNC2H1 in a Fetus with Short Rib-Polydactyly Syndrome, Type III

Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder

Targeted Exome Sequencing Identifies Novel Compound Heterozygous Mutations in P3H1 in a Fetus with Osteogenesis Imperfecta Type VIII.

A pilot study of gene testing of genetic bone dysplasia using targeted next-generation sequencing